←Back to Expert Scholars
Translational Medicine / 转化医学Senolytics, Aging Therapeutics
James Kirkland
MD, PhD
🏢Mayo Clinic🌐USA
Director, Robert and Arlene Kogod Center on Aging
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
James Kirkland pioneered senolytic therapies that selectively clear senescent cells and is leading the first human trials of senolytics in aging-related conditions. His work underpins the rationale for combining senolytics with cancer immunotherapy in older patients.
Share:
🧪Research Fields 研究领域
senolytic drugs
dasatinib quercetin
senescent cell clearance
aging clinical trials
fisetin
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 James Kirkland 的研究动态
Follow James Kirkland's research updates
留下邮箱，当我们发布与 James Kirkland（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment